Medications in type-2 diabetics and their association with liver fibrosis

World Journal of Gastroenterology : WJG
M S SiddiquiAmandeep Singh

Abstract

The prevalence of nonalcoholic fatty liver disease (NAFLD) is significantly rising worldwide. Type-2 diabetes (T2D) is a major risk factor for NAFLD progression. To assess the association of commonly used medications to advanced fibrosis (AF) in patients with biopsy-proven NAFLD and T2D. We used the International Classification of Disease 9th Revision Clinical Modification coding system to identify patients with T2D and included patients who underwent liver biopsy for suspected NAFLD between January 1, 2000 to December 31, 2015. We compared demographics, clinical characteristics, and differences in pattern of medication use in patients who had biopsy-proven AF to those without it. A univariate and multivariate analysis was performed to assess the association of different classes of medication with the presence of AF. A total of 1183 patients were included in the final analysis, out of which 32% (n = 381) had AF on liver biopsy. Mean age of entire cohort was 52 years and majority were females (65%) and Caucasians (85%). Among patients with AF, 51% were on oral hypoglycemics, 30% were on insulin, 66% were on antihypertensives and 27% were on lipid lowering agents for the median duration of 19 mo, 10 mo, 26 mo, and 24 mo respectiv...Continue Reading

References

Aug 31, 1995·The New England Journal of Medicine·M StumvollJ E Gerich
May 20, 1999·Diabetes Care·R de MarcoM Muggeo
Nov 19, 2003·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Ilyas TuncerIrfan Bayram
Dec 20, 2003·Virchows Archiv : an International Journal of Pathology·Elie Serge Zafrani
Apr 21, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ramón BatallerRichard A Rippe
Nov 11, 2006·Journal of Gastroenterology·Hitoshi Yoshiji, Hiroshi Fukui
Apr 4, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Nathalie C LeiteClaudia R L Cardoso
Oct 24, 2008·Alimentary Pharmacology & Therapeutics·R LoombaJ H Hoofnagle
Feb 18, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Kathleen E CoreyRaymond T Chung
Feb 6, 2013·The American Journal of Gastroenterology·Siddharth SinghWilliam Sanchez
Aug 21, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Geoffrey Farrell
Sep 18, 2013·Nature Reviews. Gastroenterology & Hepatology·Rohit Loomba, Arun J Sanyal
Dec 11, 2014·World Journal of Gastroenterology : WJG·Alessandro FedericoCarmela Loguercio
Dec 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiMark Wymer
Feb 10, 2016·Metabolism: Clinical and Experimental·Jonathan M HazlehurstJeremy W Tomlinson
Mar 22, 2016·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Asad Dajani, Adnan AbuHammour
Mar 25, 2016·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Qianqian ZhuZhengwen Liu
Apr 12, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
Sep 21, 2017·Nature Reviews. Gastroenterology & Hepatology·Zobair YounossiElisabetta Bugianesi
Aug 10, 2018·Indian Journal of Endocrinology and Metabolism·Mala Dharmalingam, P Ganavi Yamasandhi
Nov 11, 2018·Pharmaceuticals·Matteo TacelliSalvatore Petta
Nov 12, 2018·Journal of Hepatology·Zobair M Younossi
Dec 7, 2018·Metabolism: Clinical and Experimental·Stergios A PolyzosChristos S Mantzoros

❮ Previous
Next ❯

Citations

Jul 3, 2021·Journal of Personalized Medicine·Michele FinottiGiacomo Zanus

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies
pharmacotherapies

Software Mentioned

SAS

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.